BENDER LEWIS H 4
4 · INTENSITY THERAPEUTICS, INC. · Filed Mar 7, 2024
Insider Transaction Report
Form 4
BENDER LEWIS H
DirectorPresident and CEO10% Owner
Transactions
- Award
Stock Option (right to buy Common Stock)
2024-03-06+33,574→ 33,574 totalExercise: $5.19Exp: 2034-03-06→ Common Stock (33,574 underlying) - Award
Stock Option (right to buy Common Stock)
2024-03-06+464,805→ 464,805 totalExercise: $5.19Exp: 2034-03-06→ Common Stock (464,805 underlying)
Footnotes (2)
- [F1]This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on March 6, 2024.
- [F2]This option vested 100% on March 6, 2024.